Abstract
Lung cancer is one of the major causes of cancer-related deaths in the world. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, and small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Proper therapies for SCLC have not yet been developed. However, new molecules have been designed and big innovation in treating SCLC has been achieved. Platinum-based antitumor drugs like cisplatin and carboplatin have several disadvantages including side effects, cisplatin-resistant tumors and limited solubility in aqueous media. Thus, two novel chiral aminoalcohol-based bis(phosphinite) ligands containing (η6-p-cymene)-Ru(II)-phosphinite and bis(phosphinite)–Pd(II) complexes were synthesized and evaluated for anticancer activity. In this study, the results showed that complex 1 has the strongest cytotoxic effects on SCLC and NSCLC cell lines. On the other hand, cisplatin, ruthenium and palladium complexes are capable to induce apoptosis. Especially, complexes 1 and 2 can induce apoptosis for both SCLC and NSCLC. When compared to the qRT-PCR and TUNEL results, we obtained a significant correlation between apoptotic index and p21, Bax gene expressions. This work revealed the potential of the synthesized complexes as anticancer agents with cytotoxic and pro-apoptotic activity as leading compounds for further anticancer researches.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Bayati YWA, Karakaş DE, Meriç N, Aydemir M, Durap F, Baysal A (2018) Ferrocene based chiral binuclear η6-benzene-Ru(II)-phosphinite complexes: synthesis, characterization and catalytic activity in asymmetric reduction of ketones. Appl Organomet Chem 32:3919. https://doi.org/10.1002/aoc.3919
Antunovic M, Kriznik B, Ulukaya E, Yilmaz VT, Mihalic KC, Madunic J, Marijanovic I (2015) Cytotoxic activity of novel palladium-based compounds on leukemia cell lines. Anticancer Drugs 26(2):180–186. https://doi.org/10.1097/CAD.0000000000000174
Anzellotti AI, Sabat M, Farrell N (2006) Platination of nucleobases to enhance noncovalent recognition in protein − DNA/RNA complexes. Inorg Chem 45:1638–1645. https://doi.org/10.1021/ic049086d
Appelt P, da Silva JP, Fuganti O, Aquino L, Sandrino B, Wohnrath K, Santos VA, Cunha MAA, Veiga A, Murakami FS, Back DF, de Araujo MP (2017) New heterobimetallic ruthenium (II) com-plexes [Ru(N-S)(bipy)(dppf)]PF6: synthesis, molecular structure, electrochemistry, DFT, antioxidant and antibacterial potential. J Organomet Chem 846:326–334. https://doi.org/10.1016/j.jorganchem.2017.07.005
Arauj MP, Figueiredo AT, Bogado AL, Poelhsitz GV, Ellena J, Castellano EE, Donnici CL, Comasseto JV, Batista AA (2005) Ruthenium phosphine/diimine complexes: syntheses, characterization, reactivity with carbon monoxide, and catalytic hydrogenation of ketones. Organomets 24(25):6159–6168. https://doi.org/10.1021/om050182b
Baysal A, Karakaş DE, Meric N, Ak B, Aydemir M, Durap F (2017) Chiral phosphinites as efficient ligands for enantioselective Ru(II), Rh(I) and Ir(III)-catalyzed transfer hydrogenation reactions. Transit Met Chem 42:365–372. https://doi.org/10.1007/s11243-017-0140-1
Biricik N, Durap F, Gümgüm B, Fei Z, Scopelliti R (2007a) Synthesis and reactivity of N, N-bis (diphenylphosphino) dimethylaniline compounds. Transit Metal Chem 32(7):877–883. https://doi.org/10.1007/s11243-007-0231-5
Biricik N, Durap F, Kayan C, Gümgüm B (2007b) New bis(diphenylphosphino)aniline derivatives: synthesis and spectroscopic characterization. Heteroat Chem 18:613–616
Chen JC, Zhang Y, Jie XM, She J, Dongye GZ, Zhong Y, Deng YY, Wang J, Guo BY, Chen LM (2019) Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase. J Inorg Biochem 193:112–123. https://doi.org/10.1016/j.jinorgbio.2019.01.011
Debreczeni JE, Bullock AN, Atilla GE, Williams DS, Bregman H, Knapp S, Meggers E (2006) Ruthenium half-sandwich complexes bound to protein kinase Pim-1. Chem Int Ed 45:1580–1585. https://doi.org/10.1002/anie.200503468
Deepthi SB, Trivedi R, Sujitha P, Kumar CG, Sridhar B, Bhargava UK (2012) Synthesis, characterization and cytotoxic activity of palladium (II) carbohydrate complexes. J Chem Sci 124:1405–1413. https://doi.org/10.1007/s12039-012-0340-3
Demkowicz S, Rachon J, Dasko M, Kozak W (2016) Selected organophosphorus compounds with biological activity. Applications in medicine. RSC Adv 6:7101–7112. https://doi.org/10.1039/C5RA25446A
Deshpande MS, Kumbhar AS (2005) Mixed-ligand complexes of ruthenium(II) incorporating a diazo ligand: synthesis, characterization and DNA binding. J Chem Sci 117:153–159. https://doi.org/10.1007/BF03356110
Dong W, Wang M, Liu T, Liu X, Jin K, Sun L (2007) Preparation, structures and electrochemical property of phosphine substituted diiron azadithiolates relevant to the active site of Fe-only hydrogenases. J Inorg Biochem 101(3):506–513. https://doi.org/10.1016/j.jinorgbio.2006.11.013
Durap F, Biricik N, Gümgüm B, Özkar S, Ang WH, Fei Z, Scopelliti R (2008) Synthesis and characterizations of N, N-bis(diphenylphosphino)ethylaniline derivatives and X-ray crystal structure of palladium (II), platinum (II) complexes. Polyhedron 27:196–202. https://doi.org/10.1016/j.poly.2007.09.011
Ellahioui Y, Patra M, Mari C, Kaabi R, Karges J, Gasser G, Gómez-Ruiz S (2019) Mesoporous silica nanoparticles functionalised with a photoactive ruthenium (II) complex: exploring the formulation of a metal-based photodynamic therapy photosensitiser. Dalton Trans 48(18):5940–5951. https://doi.org/10.1039/C8DT02392A
Fanelli M, Formica M, Fusi V, Giorgi L, Micheloni M, Paoli P (2016) New trends in platinum and palladium complexes as antineoplastic agents. Coord Chem Rev 310:41–79. https://doi.org/10.1016/j.ccr.2015.11.004
Farhangian H, Moghadama ME, Divsalar A, Rahiminezhad A (2017) Anticancer activity of novel amino acid derivative of palladium complex with phendione ligand against of human colon cancer cell line. J Biol Inorg Chem 22(7):1055–1064. https://doi.org/10.1007/s00775-017-1483-y
Fiorentino FP, Tokgün E, Solé-Sánchez S, Giampaolo S, Tokgün O, Jauset T, Kohno T, Perucho M, Soucek L, Yokota J (2016) Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation. Oncotarget 7(21):31014–31028. https://doi.org/10.18632/oncotarget.8826
Gümgüm B, Akba O, Durap E, Yıldırım TL, Ülkü D, Özkar S (2006) Synthesis characterization, crystal and molecular structure of dipenyloxophosphino ethylenediamines. Polyhedron 25:3133–3137. https://doi.org/10.3390/molecules20045771
Gümgüm B, Biricik N, Durap E, Özdemir İ, Gürbüz N, Ang W, Pj Dyson (2007) Application of N, N-bis(diphenylphosphino)aniline palladium(II) complexes as pre-catalysts in Heck coupling reactions. Appl Organomet Chem 21:711–715. https://doi.org/10.1002/aoc.1253
Heydari M, Moghadam ME, Tarlani A, Farhangian H (2017) DNA as a target for anticancer phen-imidazole Pd(II) complexes. Appl Biochem Biotechnol 182:110. https://doi.org/10.1007/s12010-016-2314-2
James N, Shanthi V, Ramanathan K (2018) Drug design for ALK-positive NSCLC: an integrated pharmacophore-based 3D QSAR and virtual screening strategy. Appl Biochem Biotechnol 185:289. https://doi.org/10.1007/s12010-017-2650-x
Jiang GB, Zhang WY, He M, Gu YY, Bai L, Wang YJ, Yi QY, Du F (2019) Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro. Spectrochim Acta A Mol Biomol Spectrosc 5(220):117132. https://doi.org/10.1016/j.saa.2019.05.037
Kacar O, Adiguzel Z, Yilmaz VT, Cetin Y, Cevatemre B, Arda N, Baykal AT, Ulukaya E, Acilan C (2014) Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent. Anticancer Drugs 25(1):17–29. https://doi.org/10.1097/CAD.0b013e328364c6ad
Karakaş DE, Durap F, Aydemir M, Baysal A (2016) Synthesis, characterization and first application of chiral C2-symmetric bis(phosphinite)–Pd(II) complexes as catalysts in asymmetric intermolecular Heck reactions. Appl Organometal Chem 30:193–198. https://doi.org/10.1002/aoc.3416
Karakaş DE, Aydemir M, Durap F, Baysal A (2018) Chiral C2-symmetric η6-p-cymene-Ru(II)-phosphinite complexes: synthesis and catalytic activity in asymmetric reduction of aromatic, methyl alkyl and alkyl/aryl ketones. Inorg Chim Acta 471:430–439. https://doi.org/10.1016/j.ica.2017.11.044
Lazarevic T, Rilak A, Bugarcic ZD (2017) Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem 142:8–31. https://doi.org/10.1016/j.ejmech.2017.04.007
Lindner E, Mayor HA, Warad I, Eichele K (2003) Supported organometallic complexes: part XXXV. Synthesis, characterization, and catalytic application of a new family of diamine(diphosphine)ruthenium(II) complexes. Organomet Chem 665:176–185. https://doi.org/10.1016/S0022-328X(02)02112-5
Liu HK, Berners-Price SJ, Wang FY, Parkinson JA, Xu JJ, Bella J, Sadler PJ (2006) Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex. Chem Int Ed 45:8153–8156. https://doi.org/10.1002/anie.200602873
Meriç N, Kayan C, Rafikova K, Zazybin A, Okumuş V, Aydemir M, Durap F (2019) Synthesis of ionic liquid-based Ru(II)–phosphinite complexes and evaluation of their antioxidant, antibacterial, DNA-binding, and DNA cleavage activities. Chem Pap 73:1199–1208. https://doi.org/10.1007/s11696-018-00670-0
Miklásová N, Fischer-Fodor E, Lönnecke P, Tomuleasa CI, Virag P, Schrepler MP, Miklás R, Dumitrescu LS, Hey-Hawkins E (2012) Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Eur J Med Chem 49:41–47. https://doi.org/10.1016/j.ejmech.2011.12.001
Mjos KD, Orvig C (2014) Metallodrugs in medicinal inorganic chemistry. Chem Rev 114(8):4540–4563. https://doi.org/10.1021/cr400460s
Moghadama ME, Saidifarb M, Divsalarc A, Torshizid HM, Sabourye AA, Farhangiana H, Ghadamgahif M (2016) Rich spectroscopic and molecular dynamic studies on the interaction of cytotoxic Pt(II) and Pd(II) complexes of glycine derivatives with calf thymus DNA. J Biomol Struct Dyn 34:206–222. https://doi.org/10.1080/07391102.2015.1015056
Ok F, Aydemir M, Baysal A, Durap F (2014) Novel half-sandwich η5-Cp *–rhodium(III) and η5-Cp *–ruthenium(II) complexes bearing bis(phosphino)amine ligands and their use in the transfer hydrogenation of aromatic ketones. Appl Organometal Chem 28:38–43. https://doi.org/10.1002/aoc.3068
Onar G, Gürses C, Karataş MO, Balcıoğlu S, Akbay N, Özdemir N, Ateş B, Alıcı B (2019) Palladium(II) and ruthenium(II) complexes of benzotriazole functionalized N-heterocyclic carbenes: cytotoxicity, antimicrobial, and DNA interaction studies. J Organomet Chem 886:48–56. https://doi.org/10.1016/j.jorganchem.2019.02.013
Patel MN, Patel CR, Joshi HN (2013) Metal-based biologically active compounds: synthesis, characterization, DNA interaction, antibacterial, cytotoxic and SOD mimic activities. Appl Biochem Biotechnol 169(4):1329–1345. https://doi.org/10.1007/s12010-012-0086-x
Pettinari R, Marchetti F, Condello F, Pettinari C, Lupidi G, Scopelliti R, Mukhopadhyay S, Riedel T, Dyson PJ (2014) Ruthenium(II)–Arene RAPTA type complexes containing curcumin and bisdemethoxycurcumin display potent and selective anticancer activity. Organometallics 33:3709–3715. https://doi.org/10.1021/om500317b
Priyarega S, Kalaivani P, Prabhakaran R, Hashimoto T, Endo A, Natarajan K (2011) Nickel(II) complexes containing thiosemicarbazone and triphenylphosphine: synthesis, spectroscopy, crystallography and catalytic activity. J Mol Struct 1002:58–62. https://doi.org/10.1016/j.molstruc.2011.06.046
Richert M, Budzisz E (2010) Ruthenium complexes in cancer therapy. Wiad Chem 64:357
Rocha F, Barra C, Netto AG, Mauro AE, Carlos I, Frem RCG, Ananias S, Quilles M, Stevanato A, Rocha M (2010) 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity. Eur J Med Chem 45:1698–1702. https://doi.org/10.1016/j.ejmech.2009.12.073
Ruiz J, Lorenzo J, Vicente C, López G, Monge M, Avilés FX, Bautista D, Moreno V, Laguna A (2008a) New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity. Inorg Chem 47:6990–7001. https://doi.org/10.1021/ic800589m
Ruiz J, Villa MD, Cutillas N, López G, de Haro C, Bautista D, Moreno V, Valencia L (2008b) Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds. Inorg Chem 47:4490. https://doi.org/10.1021/ic701873b
Shabbir M, Akhter Z, Ashraf AR, Ismail H, Anum H, Mirza B (2017) Nickel(II) and palladium(II) triphenylphosphine complexes incorporating tridentate Schiff base ligands: synthesis, characterization and biocidal activities. J Mol Struct 1149:720–726. https://doi.org/10.1016/j.molstruc.2017.08.050
Tokgun O, Demiray A, Bulent K, Akca H (2015) Silica nanoparticles can induce apoptosis via dead receptor and caspase 8 pathway on A549 cells. Adv Food Sci 2:65–70
Wani WA, Prashar S, Shreaz S, Gómez-Ruiz S (2016) Nanostructured materials functionalized with metal complexes: in search of alternatives for administering anticancer metallodrugs. Coord Chem Rev 312:67–98. https://doi.org/10.1016/j.ccr.2016.01.001
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tokgun, O., Karakas, D.E., Tan, S. et al. Novel ruthenium and palladium complexes as potential anticancer molecules on SCLC and NSCLC cell lines. Chem. Pap. 74, 2883–2892 (2020). https://doi.org/10.1007/s11696-020-01129-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11696-020-01129-x